Ritonavir (CAS 155213-67-5): R&D Systems
IJMS | Free Full-Text | The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
Structures of the boosters (CYP inhibitors) ritonavir and cobicistat,... | Download Scientific Diagram
Ritonavir | C37H48N6O5S2 | CID 392622 - PubChem
HIV Antiretroviral Pharmacokinetic Boosters - Ritonavir ... | GrepMed
Trial profile. DTG, dolutegravir; PI/r, ritonavir-boosted protease... | Download Scientific Diagram
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment | Scientific Reports
Ritonavir boosting of low-dose danoprevir (RG7227; ITMN-191), HCV NS3/4A protease inhibitor, results in robust reduction in HCV RNA at lower exposures than provided by unboosted regimens
Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens | PLOS ONE
Ritonavir (Norvir)
Biomedicines | Free Full-Text | Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study - The Lancet HIV
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19
Lopinavir/ritonavir - Wikipedia
Ritonavir 155213-67-5 | TCI AMERICA
How Ritonavir acts as booster drug - YouTube
Adrenal insufficiency due to ritonavir-triamcinolone drug–drug interaction without preceding Cushing's syndrome - S Noe, H Jaeger, S Heldwein, 2018
Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients. | Semantic Scholar
Lopinavir-ritonavir does not suppress SARS-CoV-2 activity in vitro
Switch to RPV-TDF-FTC from Ritonavir-boosted PI Regimen SPIRIT STUDY - ppt download
How Ritonavir acts as booster drug - YouTube
The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins - ScienceDirect
